


Healthcare Industry News: Zerusa
News Release - July 9, 2007
Zerusa Limited and Vascular Solutions Announce U.S. Distribution of Guardian Hemostasis Valve
MINNEAPOLIS and GALWAY, Ireland, July 9, 2007 (Healthcare Sales & Marketing Network) -- Zerusa Limited and Vascular Solutions, Inc. (NasdaqGM:VASC ) today announced that they have entered into a distribution agreement providing for Vascular Solutions to distribute Zerusa's Guardian(r) hemostasis valve in the United States. The Guardian Hemostasis Valve is designed to maintain hemostasis during interventional catheterization procedures through a novel easy-to-use sealing system which allows simple introduction and removal of interventional devices while providing the option to lock wires in place. The valve is currently sold in Europe through Zerusa's distribution network and has received 510(k) clearance with the FDA for sales in the United States.Howard Root, Chief Executive Officer of Vascular Solutions, commented: ``This is an excellent addition to our Access Products line, and we are pleased to be able to work with the Zerusa organization on this and hopefully several future product distribution partnerships. We already have performed initial clinical evaluations of the valve with excellent results, and a launch through our 80+ employee direct U.S. sales force is expected following our July national sales meeting.''
Ger Brett, Chief Executive Officer of Zerusa Limited, commented: ``This distribution agreement with Vascular Solutions is an important milestone in further developing market acceptance for the innovative Guardian Hemostasis Valve. The combination of our product with Vascular Solutions' well respected, clinical based direct U.S. sales organization is well-suited to the opportunity.''
About Zerusa Limited
Zerusa Limited is a Galway, Ireland based medical device company which designs, develops and delivers clinically-driven, best-in-class products and services in partnership with clinicians, academia and industry in the most efficient, value-driven manner.
About Vascular Solutions
Vascular Solutions, Inc. is a medical device company that focuses on developing unique solutions for unmet clinical opportunities within interventional radiology and interventional cardiology. The company's five main product categories consist of hemostat (blood clotting) products, extraction catheters, vein products, specialty catheters and access products. New products introduced since the second half of 2003 include the D-Stat Dry hemostatic bandage for the rapid control of topical bleeding, the Pronto extraction catheter for the aspiration of soft thrombus, the Langston(r) dual lumen specialty catheter for the measurement of aortic stenosis, the Vari-Lase(r) endovenous laser product line for the treatment of varicose veins, and the Twin-Pass(r) dual access specialty catheter for dual wire access in interventional procedures.
The information in this press release contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements. Important factors that may cause such differences include those discussed in our Annual Report on Form 10-K for the year ended December 31, 2006 and other recent filings with the Securities and Exchange Commission. The risks and uncertainties include, without limitation, risks associated with the need for adoption of our new products, limited working capital, lack of profitability, exposure to intellectual property claims, dependence on key vendors, exposure to possible product liability claims, the development of new products by others, doing business in international markets, limited manufacturing experience, the availability of third party reimbursement, and actions by the FDA.
For further information, connect to http://www.vascularsolutions.com.
Source: Vascular Solutions
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
